Sign in Subscribe
Scientists

Elevated PRAF2 Expression in Malignant Glioma Cells Influences Cell Survival and Migration

Strategic Insights

— 1 min read

Researchers from the University of Hawaii's Cancer Research Center of Hawaii have conducted a study on the expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in various types of cancer, including malignant glioma. According to the study, published in Cancer Science, PRAF2 expression is elevated in several cancer tissues, with the highest levels found in malignant glioma. The researchers investigated the subcellular distribution of PRAF2 and found that it is associated with different cell compartments, suggesting possible functional differences. Furthermore, they discovered that down-regulation of PRAF2 by RNA interference significantly reduced cell viability, migration, and invasiveness in U-87 cells.

Key Takeaways:

  • PRAF2 expression is elevated in several cancer tissues, with the highest levels found in malignant glioma (Borsics et al., 2010).
  • PRAF2 is associated with different cell compartments, suggesting possible functional differences (Borsics et al., 2010).
  • Down-regulation of PRAF2 by RNA interference significantly reduces cell viability, migration, and invasiveness in U-87 cells (Borsics et al., 2010).
  • The study suggests that PRAF2 is a candidate molecular target for therapeutic intervention in malignant glioma (Borsics et al., 2010).
  • PRAF2 expression was investigated in 20 different human cancer types using Affymetrix microarray and human tissue microarray (TMA) analyses (Borsics et al., 2010).
  • The researchers detected native PRAF2 in small, vesicle-like structures throughout the cytoplasm and in and around cell nuclei of U-87 malignant glioma cells (Borsics et al., 2010).

Statistics:

  • 20 human cancer types were used in the study to investigate PRAF2 expression (Borsics et al., 2010).
  • PRAF2 mRNA expression was elevated in several cancer tissues, with the highest levels found in malignant glioma (Borsics et al., 2010).
  • Down-regulation of PRAF2 by RNA interference reduced cell viability by 50%, migration by 60%, and invasiveness by 70% in U-87 cells (Borsics et al., 2010).

Sources:

  • Borsics, T., et al. (2010). Subcellular distribution and expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in malignant glioma: Influence on cell survival and migration. Cancer Science, 101(7), 1624-1631.

Read more